← FDA Drug Approvals (Drugs@FDA)

DASATINIB

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2025-08-27

Drug application

FDA Application #

ANDA211094

Application type

Abbreviated New Drug Application (Generic)

Brand name

DASATINIB

Generic name

DASATINIB

Active ingredients

DASATINIB

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

TEVA PHARMS USA

Manufacturer

Teva Pharmaceuticals, Inc.

First approval

2025-08-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown